| 747 |
Centers for Disease Control and Prevention |
Html |
en |
Outbreak of Escherichia coli O104:H4 Infections Associatedwith Sprout Consumption - Europe and North America, May-July2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| outbreak vehicle | 0.345529 |
| robust public health | 0.411199 |
| Foodborne Outbreak Listserv | 0.418584 |
| Shiga toxin | 0.359822 |
| raw sprouts | 0.325763 |
| Escherichia coli | 0.365278 |
| public health authorities | 0.516905 |
| German HUS patients | 0.362963 |
| U.S. Department | 0.340705 |
| Health Alert Network | 0.326736 |
| STEC diagnostic testing | 0.450257 |
| Shiga toxin–positive stool | 0.331072 |
| outbreak management | 0.347476 |
| outbreak | 0.590926 |
| foodborne disease surveillance | 0.328541 |
| novel STEC pathogens | 0.522365 |
| non-O157 illness-causing STEC | 0.453281 |
| traceback investigations | 0.405795 |
| German public health | 0.350442 |
| laboratory-confirmed STEC infections | 0.447817 |
| World Health Organization | 0.331356 |
| Shiga toxin–positive specimens | 0.32799 |
| STEC outbreak worldwide | 0.562952 |
| state public health | 0.342271 |
| public health laboratories | 0.403645 |
|
| International Health Regulations | 0.331584 |
| new cases | 0.332476 |
| Germany | 0.326181 |
| public health infrastructure | 0.482923 |
| outbreak pathogens | 0.362877 |
| Shiga toxin–positive diarrheal | 0.344198 |
| United States | 0.785287 |
| hemolytic uremic syndrome | 0.387413 |
| STEC O104 | 0.930263 |
| non-O157 STEC | 0.538006 |
| U.S. cases | 0.33411 |
| public health | 0.75801 |
| outbreak strain | 0.462891 |
| Enteroaggregative STEC O104 | 0.504362 |
| cases | 0.432546 |
| STEC testing recommendations | 0.508094 |
| HUS | 0.378674 |
| STEC diarrheal illness | 0.504688 |
| HUS cases | 0.350066 |
| Robert Koch Institute | 0.391968 |
| raw fenugreek sprouts | 0.433152 |
| large outbreak | 0.345798 |
| STEC O157 | 0.464461 |
| food consumption commonalities | 0.331115 |
|
CLICK HERE |
| 4736 |
Centers for Disease Control and Prevention |
Html |
en |
Eastern Equine Encephalitis - Arboviral Diagnostic Testing |
Eastern Equine Encephalitis is a rare disease that is caused by a virus spread by infected mosquitoes.
|
| arbovirus activity increases | 0.755158 |
| initial results | 0.475105 |
| fatal cases | 0.479542 |
| CDC | 0.320276 |
| histopathology | 0.268133 |
| Microsphere-Based Immunoassay | 0.466658 |
| confirmatory testing | 0.443563 |
| virus-specific IgM | 0.598843 |
| APPROPRIATE STATE HEALTH | 0.644131 |
| final results | 0.447749 |
| state health department | 0.94534 |
| patient | 0.280121 |
| specimen receipt | 0.511579 |
| CSF | 0.299929 |
| Initial serological testing | 0.710934 |
| Laboratory diagnosis | 0.477449 |
| antibodies | 0.257283 |
| nucleic acid amplification | 0.723214 |
| immunohistochemistry | 0.268758 |
| area | 0.24686 |
| arboviral infections | 0.538003 |
|
| test results | 0.651322 |
| MIA | 0.251833 |
| epidemiologic history | 0.522521 |
| dates | 0.247121 |
| Instructions | 0.241315 |
| virus culture | 0.462514 |
| autopsy tissues | 0.502588 |
| DVBID Arbovirus Diagnostic | 0.798779 |
| hard copy | 0.441693 |
| Preliminary diagnosis | 0.501719 |
| places | 0.247164 |
| IgM capture ELISA | 0.78432 |
| diagnostic specimens | 0.457961 |
| activities | 0.246795 |
| location | 0.246642 |
| IgG ELISA | 0.530671 |
| state laboratories | 0.471293 |
| serum | 0.27277 |
| travel | 0.247077 |
| non-endemic country | 0.490728 |
|
CLICK HERE |
| 4823 |
Centers for Disease Control and Prevention |
Html |
en |
Upstream ecological risks for overweight and obesity among African American youth in a rural town in the Deep South, 2007 |
null |
| high school | 0.671122 |
| school board member | 0.570448 |
| ecological theory | 0.560775 |
| multiple ecological levels | 0.557328 |
| local high school | 0.517367 |
| in-depth interviews | 0.530755 |
| issues | 0.524764 |
| recreational center | 0.522832 |
| complex community contexts | 0.556882 |
| youth resource center | 0.52676 |
| African American student | 0.545668 |
| rural community settings | 0.53977 |
| community coalition members | 0.536659 |
| right social connections | 0.543378 |
| African American families | 0.537743 |
| white community members | 0.605576 |
| community | 0.831912 |
| upstream ecological factors | 0.568684 |
| embodiment theory | 0.584683 |
| African American teachers | 0.548252 |
| specific rural communities | 0.524595 |
| specific community contexts | 0.673013 |
| qualitative community health | 0.557917 |
| African American students | 0.546638 |
| rural town | 0.548008 |
|
| African American children | 0.534995 |
| African American pastor | 0.542716 |
| African American members | 0.555722 |
| Georgia Southern University | 0.612882 |
| white American populations | 0.534485 |
| local health department | 0.517281 |
| African American community | 0.731071 |
| larger community health | 0.550864 |
| American community members | 0.648857 |
| participants | 0.674353 |
| African American women | 0.534257 |
| rural youth | 0.522121 |
| African American representative | 0.546315 |
| rural communities | 0.540218 |
| race | 0.5435 |
| community organizations | 0.535061 |
| Deep South | 0.64514 |
| rural community | 0.572343 |
| African American youth | 0.984297 |
| physical activity | 0.541702 |
| community health assessment | 0.623387 |
| illegal drug activity | 0.551447 |
| upstream levels | 0.530593 |
| healthful food options | 0.556908 |
|
CLICK HERE |
| 5070 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, November 09, 2009 |
null |
| Centers | 0.316662 |
| endorsement | 0.396275 |
| Pan_Pox | 0.317357 |
| current awareness | 0.398845 |
| Articles | 0.317148 |
| methods | 0.316549 |
| findings | 0.339957 |
| poxviruses detection | 0.401167 |
| Prevention | 0.316624 |
| G+C content | 0.398288 |
| inclusion | 0.319444 |
| Disease Control | 0.396855 |
| responsibility | 0.317408 |
| CDC Knowledge | 0.595157 |
| Action Science Clips | 0.915001 |
| factual accuracy | 0.401171 |
| omission | 0.325679 |
| views | 0.332321 |
| informational purposes | 0.391174 |
| Chief Science Officer | 0.501227 |
|
| conclusions | 0.319787 |
| public health literature | 0.477276 |
| permission | 0.321753 |
| B. Thacker CDC | 0.814108 |
| original authors | 0.388267 |
| article | 0.329399 |
| DHHS | 0.464409 |
| opinion | 0.331281 |
| non-CDC Websites | 0.392995 |
| universal PCR | 0.403454 |
| original sources | 0.396644 |
| DISCLAIMER | 0.325488 |
| selection | 0.316054 |
| service | 0.319393 |
| References | 0.316044 |
| public domain | 0.401592 |
| news sources | 0.390144 |
| Stephen B. Thacker | 0.698037 |
| items | 0.349743 |
|
CLICK HERE |
| 5958 |
Centers for Disease Control and Prevention |
Html |
en |
Methyl ethyl ketone peroxide - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6544 |
Centers for Disease Control and Prevention |
Html |
en |
CDC and Dengue Research - Dengue Fever |
CDC Works For You 24/7 Protecting People - Working to Protect Against the Dangers of Dengue - Dengue, a painful and sometimes deadly viral disease transmitted by mosquitoes, threatens more than 3.5 billion people worldwide. Dengue is endemic in at least 100 countries in Southeast Asia, the Pacific Islands, the Caribbean, Central America, South America, and parts of Africa. As many as 100 million people become infected yearly, and nearly 500,000, mostly children, develop the potentially deadly dengue hemorrhagic fever. |
| study mosquito-borne viruses | 0.326577 |
| best way | 0.323989 |
| virology lab | 0.269779 |
| ongoing efforts | 0.258936 |
| mosquito-transmitted disease | 0.274399 |
| Dr. Harold Margolis | 0.314723 |
| Claire Huang | 0.26602 |
| vaccine adoption strategies | 0.406326 |
| CDC program | 0.282028 |
| vector-borne diseases | 0.350594 |
| opportunity | 0.210869 |
| dengue experts | 0.538989 |
| international meeting | 0.263998 |
| dengue vaccine | 0.974188 |
| Scientists | 0.212651 |
| successful vaccine | 0.387244 |
| unique strength | 0.273401 |
| vaccination | 0.211249 |
| Puerto Rico | 0.441347 |
| dengue vaccine development | 0.699192 |
| production | 0.212615 |
| largest research unit | 0.327905 |
| southern Taiwan | 0.267147 |
| dengue vaccine research | 0.724541 |
| major activity | 0.272016 |
|
| Dengue v2V | 0.591152 |
| epidemiologic | 0.213935 |
| world | 0.211683 |
| Dengue Branch | 0.623567 |
| introduction | 0.218812 |
| Public health aspects | 0.337484 |
| San Juan | 0.269035 |
| CSU | 0.229765 |
| agency | 0.212424 |
| economic impact | 0.262027 |
| epidemic dengue activity | 0.581051 |
| relevant venue | 0.260143 |
| disease. | 0.212657 |
| dengue virus research | 0.658411 |
| people | 0.210793 |
| Colorado State University | 0.321352 |
| master | 0.211439 |
| life-long passion | 0.266248 |
| co-chair | 0.216381 |
| major dengue outbreak | 0.618503 |
| DVBD | 0.211723 |
| catch-up immunization | 0.263102 |
| technical data | 0.26171 |
| decades | 0.212727 |
|
CLICK HERE |
| 9176 |
Centers for Disease Control and Prevention |
Html |
en |
Prostate Cancer Rates by Race and Ethnicity |
Prostate cancer statistics from CDC: incidence and mortality by race and ethnicity. |
| numbers | 0.421228 |
| invasive cancer sites | 0.598755 |
| NVSS | 0.424124 |
| cancer excludes basal | 0.603825 |
| genital organs | 0.500593 |
| number | 0.463046 |
| shows | 0.46358 |
| ethnic populations | 0.601836 |
| A/PI | 0.419389 |
| Asian/Pacific Islander men | 0.601713 |
| registry-specific data quality | 0.585333 |
| prostate cancer incidence | 0.680285 |
| highest rate | 0.519055 |
| Hispanic origin | 0.601906 |
| National Vital Statistics | 0.574286 |
| Behavior recode | 0.508481 |
| National Program | 0.502499 |
| incidence rate | 0.639841 |
| age groups | 0.601885 |
| Sources | 0.419304 |
| graph | 0.470666 |
| Census P25–1130 | 0.604088 |
| population coverage | 0.602983 |
| data quality | 0.590945 |
| persons | 0.477805 |
|
| situ cancers | 0.502546 |
| death rates | 0.658072 |
| U.S. standard population | 0.7643 |
| AI/AN | 0.419413 |
| ethnicity | 0.484815 |
| 100,000 | 0.462855 |
| skin | 0.43263 |
| USCS technical notes | 0.938698 |
| data quality criteria | 0.58474 |
| cancer registries | 0.606121 |
| potential differences | 0.596273 |
| Asian/Pacific Islander | 0.633069 |
| †Race categories | 0.599682 |
| *Rates | 0.437861 |
| National Cancer Institute | 0.607294 |
| caution | 0.509713 |
| disease | 0.421074 |
| black men | 0.583168 |
| urinary bladder | 0.501382 |
| End Results program | 0.595054 |
| squamous cell carcinomas | 0.597043 |
| U.S. population | 0.59581 |
| prostate cancer | 0.907235 |
| American Indian/Alaska Native | 0.795329 |
|
CLICK HERE |
| 10117 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Information Statement: Td (Tetanus, Diphtheria) - Vaccines - CDC |
Td (Tetanus Diphtheria) VIS |
| Compensation Program | 0.270031 |
| Vaccine Safety site | 0.45778 |
| Severe Problems | 0.327061 |
| vision changes | 0.279461 |
| Page | 0.342196 |
| painful muscle | 0.291177 |
| National Vaccine Injury | 0.447483 |
| tetanus | 0.39162 |
| unusual behavior | 0.274297 |
| nearest hospital | 0.275992 |
| severe allergies | 0.332716 |
| severe allergic reaction | 0.773582 |
| heart failure | 0.284673 |
| fast heartbeat | 0.277368 |
| Mild Problems | 0.284832 |
| severe allergy | 0.33121 |
| Vaccine Adverse Event | 0.451828 |
| usual activities | 0.277895 |
| Tetanus-causing bacteria | 0.290682 |
| VAERS website | 0.289389 |
| life-threatening allergic reaction | 0.383761 |
| booster dose | 0.283743 |
| person | 0.360024 |
| severe complications | 0.347153 |
| previous dose | 0.284358 |
|
| difficulty breathing | 0.27198 |
| breathing problems | 0.284431 |
| vaccination | 0.281763 |
| VICP website | 0.273198 |
| United States | 0.380659 |
| vaccines | 0.312574 |
| medical advice | 0.276654 |
| best medical care | 0.359471 |
| remote chance | 0.274477 |
| state health department | 0.339836 |
| medical attention | 0.338306 |
| vaccine package insert | 0.457301 |
| Current Edition Date | 0.373176 |
| diphtheria | 0.397539 |
| dirty wound | 0.283505 |
| Td vaccine | 0.921304 |
| time limit | 0.273637 |
| Mild fever | 0.286146 |
| severe pain | 0.386836 |
| people | 0.347813 |
| certain vaccines | 0.283137 |
| medical procedure | 0.277697 |
| doctor | 0.284351 |
| federal program | 0.272155 |
|
CLICK HERE |
| 11299 |
Centers for Disease Control and Prevention |
Html |
en |
What U.S. Hospitals Need to Know to Prepare for Ebola Virus Disease - Conference Call August 5, 2014 | Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| impacted countries | 0.485042 |
| United States | 0.444016 |
| patients | 0.326601 |
| Ebola hemorrhagic fever | 0.809932 |
| U.S. hospitals | 0.457057 |
| updates | 0.323667 |
| steps | 0.331951 |
| American citizens | 0.454404 |
| COCA | 0.348577 |
|
| guidance | 0.329852 |
| recent Ebola virus | 0.821637 |
| West Africa | 0.551427 |
| U.S. healthcare facilities | 0.549834 |
| outbreak | 0.402273 |
| clinicians | 0.339802 |
| U.S. hospital | 0.433922 |
| possibility | 0.387737 |
|
CLICK HERE |
| 12085 |
Centers for Disease Control and Prevention |
Html |
en |
Healthy Places - Recent Accomplishments - Healthy Community Design Data |
Designing and Building Healthy Places |
| Travel Survey data | 0.65619 |
| potential health effects | 0.714037 |
| health impact assessment | 0.718178 |
| health impact | 0.807927 |
| unhealthy air quality | 0.660423 |
| health disparities | 0.639548 |
| bicycling routes | 0.61182 |
| pedestrian crossing islands | 0.733515 |
| positive health outcomes | 0.714705 |
| transportation modeling techniques | 0.663586 |
| busy street crossings | 0.657354 |
| transportation systems | 0.619605 |
| adverse birth outcomes | 0.672122 |
| scale design interventions | 0.692549 |
| Community Design Initiative | 0.653302 |
| Enhanced pedestrian crossing | 0.728271 |
| community design | 0.656001 |
| traditional public health | 0.710544 |
| Health Tool | 0.633194 |
| HIA data | 0.620338 |
| annual medical cost | 0.673165 |
| health criteria | 0.626535 |
| American Planning Association | 0.642461 |
| times more pedestrian | 0.65527 |
|
| health care utilization | 0.711235 |
| specialized surface treatments | 0.657192 |
| transportation infrastructure | 0.607046 |
| United States | 0.65964 |
| adverse health outcomes | 0.723539 |
| adverse health effects | 0.729804 |
| Physical Activity Guidelines | 0.713585 |
| Metropolitan Planning Organization | 0.641446 |
| physical activity.2 | 0.615112 |
| public health | 0.739708 |
| potential public health | 0.715002 |
| regional comprehensive plans | 0.640442 |
| bicyclist fatalities | 0.607719 |
| pedestrian bridges | 0.643395 |
| high school students | 0.674671 |
| physical activity | 0.964527 |
| pedestrian crossing signals | 0.868926 |
| commonly reported form | 0.664088 |
| National Park Service | 0.640571 |
| transportation planning | 0.620292 |
| health-promotive built environment | 0.651989 |
| Health impact assessments | 0.703604 |
| Phys Act Health. | 0.646091 |
| Health Workbook | 0.630877 |
|
CLICK HERE |